| Year |
Citation |
Score |
| 2022 |
Reininger KA, Onyeaghala G, Anderson-Haag T, Schladt D, Wu B, Guan W, Dorr CR, Remmel R, Mannon R, Matas A, Oetting WS, Stahler P, Israni A, Jacobson PA. Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers. Clinical Transplantation. e14893. PMID 36571802 DOI: 10.1111/ctr.14893 |
0.305 |
|
| 2021 |
Al-Kofahi M, Oetting WS, Schladt DP, Remmel RP, Guan W, Wu B, Dorr CR, Mannon RB, Matas AJ, Israni AK, Jacobson PA. Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry. Journal of Clinical Pharmacology. PMID 33512723 DOI: 10.1002/jcph.1823 |
0.336 |
|
| 2020 |
Nguyen TT, Pearson RA, Mohamed ME, Schladt DP, Berglund D, Rivers Z, Skaar DJ, Wu B, Guan W, van Setten J, Keating BJ, Dorr C, Remmel RP, Matas AJ, Mannon RB, et al. Pharmacogenomics in kidney transplant recipients and potential for integration into practice. Journal of Clinical Pharmacy and Therapeutics. PMID 32662547 DOI: 10.1111/Jcpt.13223 |
0.413 |
|
| 2019 |
Mohamed ME, Schladt DP, Guan W, Wu B, van Setten J, Keating B, Iklé D, Remmel RP, Dorr CR, Mannon RB, Matas AJ, Israni AK, Oetting WS, Jacobson PA. Tacrolimus Troughs and Genetic Determinants of Metabolism in Kidney Transplant Recipients: A comparison of four ancestry groups. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 30953600 DOI: 10.1111/Ajt.15385 |
0.405 |
|
| 2019 |
Oetting WS, Wu B, Schladt DP, Guan W, van Setten J, Keating BJ, Iklé D, Remmel RP, Dorr CR, Mannon RB, Matas AJ, Israni AK, Jacobson PA. Genetic Variants Associated with Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome Wide Association Studies. Transplantation. PMID 30801552 DOI: 10.1097/Tp.0000000000002625 |
0.444 |
|
| 2019 |
Oetting WS, Schladt DP, Dorr CR, Wu B, Guan W, Remmel RP, Iklé D, Mannon RB, Matas AJ, Israni AK, Jacobson PA. Analysis of 75 Candidate SNPs Associated with Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A. Transplantation. PMID 30801535 DOI: 10.1097/Tp.0000000000002659 |
0.452 |
|
| 2018 |
Dorr CR, Wu B, Remmel RP, Muthusamy A, Schladt DP, Abrahante JE, Guan W, Mannon RB, Matas AJ, Oetting WS, Jacobson PA, Israni AK. Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing. The Pharmacogenomics Journal. PMID 30442921 DOI: 10.1038/S41397-018-0063-Z |
0.436 |
|
| 2018 |
Seibert SR, Schladt DP, Wu B, Guan W, Dorr C, Remmel RP, Matas AJ, Mannon RB, Israni AK, Oetting WS, Jacobson PA. Tacrolimus Trough and Dose Intra-Patient Variability and CYP3A5 Genotype: Effects on Acute Rejection and Graft Failure in European American and African American Kidney Transplant Recipients. Clinical Transplantation. e13424. PMID 30318646 DOI: 10.1111/Ctr.13424 |
0.436 |
|
| 2018 |
Scheibner A, Remmel R, Schladt D, Oetting W, Guan W, Wu B, Dorr C, Israni A, Jacobson PA. Tacrolimus Elimination in Four Patients with a CYP3A5*3/*3 CYP3A4*22/*22 Genotype. Pharmacotherapy. PMID 29804290 DOI: 10.1002/Phar.2131 |
0.401 |
|
| 2018 |
Oetting WS, Wu B, Schladt DP, Guan W, Remmel RP, Dorr C, Mannon RB, Matas AJ, Israni AK, Jacobson PA. Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients. Pharmacogenomics. PMID 29318894 DOI: 10.2217/Pgs-2017-0187 |
0.397 |
|
| 2018 |
Israni AK, Jacobson PA, Guan W, Dorr CR, van Setten J, de Borst MH, Stapleton CP, Phelan PJ, Conlon PJ, Birdwell KA, Reindl-Schwaighofer R, Heinzel A, Bakker SJ, Cavelleri G, Oetting WS, et al. Genome-Wide Association Meta-Analysis for Acute Rejection of Kidney Transplants Transplantation. 102: S27. DOI: 10.1097/01.Tp.0000542576.73240.16 |
0.423 |
|
| 2017 |
Oetting WS, Dorr C, Remmel RP, Matas AJ, Israni AK, Jacobson PA. Concepts of Genomics in Kidney Transplantation. Current Transplantation Reports. 4: 116-123. PMID 29123971 DOI: 10.1007/S40472-017-0153-X |
0.443 |
|
| 2017 |
Dorr CR, Oetting WS, Jacobson PA, Israni AK. Genetics of Acute Rejection after Kidney Transplantation. Transplant International : Official Journal of the European Society For Organ Transplantation. PMID 29030886 DOI: 10.1111/Tri.13084 |
0.46 |
|
| 2016 |
Dorr CR, Freedman BI, Hicks PJ, Brown WM, Russell GB, Julian BA, Pastan SO, Gautreaux MD, Muthusamy A, Chinnakotla S, Hauptfeld V, Bray RA, Kirk AD, Divers J, Israni AK. Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes. Plos One. 11: e0152775. PMID 27054572 DOI: 10.1371/Journal.Pone.0152775 |
0.41 |
|
| 2015 |
Oetting WS, Schladt DP, Guan W, Miller MB, Remmel RP, Dorr C, Sanghavi K, Mannon RB, Herrera B, Matas AJ, Salomon DR, Kwok PY, Keating BJ, Israni AK, Jacobson PA, et al. Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 26485092 DOI: 10.1111/Ajt.13495 |
0.49 |
|
| 2015 |
Dorr C, Wu B, Guan W, Muthusamy A, Sanghavi K, Schladt DP, Maltzman JS, Scherer SE, Brott MJ, Matas AJ, Jacobson PA, Oetting WS, Israni AK. Differentially expressed gene transcripts using RNA sequencing from the blood of immunosuppressed kidney allograft recipients. Plos One. 10: e0125045. PMID 25946140 DOI: 10.1371/Journal.Pone.0125045 |
0.393 |
|
| 2011 |
Dorr CR, Yemets S, Kolomitsyna O, Krasutsky P, Mansky LM. Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication. Bioorganic & Medicinal Chemistry Letters. 21: 542-5. PMID 21084190 DOI: 10.1016/J.Bmcl.2010.10.078 |
0.416 |
|
| Show low-probability matches. |